More News
8 October 2021
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases6 October 2021
Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics5 October 2021
Exo Therapeutics Raises $78 Million Series B Financing30 September 2021
Merck to Acquire Acceleron Pharma Inc.30 September 2021
Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases29 September 2021
AstraZeneca to fully acquire Caelum Biosciences27 September 2021
New startup Aglaia Therapeutics raises €4M in seed funding to overcome resistance in oncology targeted therapies23 September 2021
AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity21 September 2021
Novartis acquires Arctos Medical, expanding optogenetics portfolio to bring gene therapies to patients with severe vision loss21 September 2021
Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches21 September 2021
Gubra ApS and Bayer AG collaborate to develop next generation cardiorenal treatments15 September 2021
AbCellera Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines15 September 2021
Nuvectis Pharma In-Licenses Exclusive Worldwide Rights to a Novel SRC/YES1 Inhibitor (NXP900) from the University of Edinburgh, Scotland14 September 2021
Vipergen Establishes Research Partnership with PhoreMost Focused on DNA Encoded Library (DEL)-Based Drug Discovery14 September 2021
AbbVie and REGENXBIO Announce Eye Care Collaboration11 September 2021
Flamingo Therapeutics Expands Alliance with Ionis Pharmaceuticals to Develop RNA-targeted Therapies for Oncology11 September 2021
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration September 9, 202110 September 2021
ADARx Raises $75 Million to Advance Growing Pipeline9 September 2021
PAQ Therapeutics Announces Collaboration with Insilico Medicine to Develop Novel Therapies through Autophagy-Dependent Degradation9 September 2021
Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation from Founding Investor Versant VenturesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports